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The binding of [3Hjphenobarbital to rat brain membranes was studied in order to determine its 
characteristics and specificity. The binding reaction was rapid and occurred at sites of low affinity. 
(Kd = 700 f'M) and very high density (Bmax = 2.7 nmollmg protein). It was unaffected by temperature 
changes from O°C to 95°C and was maximal at pH 5. Detergents in low concentrations markedly decreas-
ed the binding, apparently without solubilizing the binding sites. It is concluded that the binding of 
[3Hjphenobarbital is a rather non-specific interaction with the plasma membrane. 
The mechanism of action of barbiturates is still unclear [7]. Some authors favor 
an interaction with plasma membrane lipids [13], which may induce a change in 
membrane fluidity [4, 5] and consequently an alteration of membrane protein func-
tioning [15]. Others, however, have reported specific interactions of barbiturates 
with membrane proteins, which may be responsible for the mediation of their 
anesthetic and anticonvulsant properties [1, 8]. In particular, effects on receptors 
such as the GABA-benzodiazepine receptor: complex [11], the adenosine A,(Ri) 
receptor [9] and the thyrotropin-releasing hormone (TRH) receptor [6] have been 
observed. 
In this context radio ligand binding studies might be useful in determining the site 
of action of barbiturates. Using this technique, Willow et al. [17] reported the ex-
istence of eH]phenobarbital binding sites in rat brain membranes and suggested 
that the study of this binding process might be of use in the investigation of the 
mechanism of action of barbiturates. Therefore we have studied the binding of 
eH]phenobarbital to brain membranes in order to determine its characteristics and 
possible relevance. 
Crude synaptosomal membranes from rat brain were prepared as described by 
Willow and Johnston [18]. Briefly stated, rat forebrains were homogenized in 10 
vols. of 0.32 M sucrose with a glass-Teflon homogenizer and the homogenate cen-
trifuged at 1000 g for 10 min. The supernatant was again centrifuged at 14,500 g 
for 20 min. The pellet was resuspended in 20 vols. of 50 mM Tris-citrate buffer, pH 
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7.1, and centrifuged as above; this washing step was repeated 5 times. Finally the 
pellet was resuspended in the same buffer at a protein concentration of 10-15 
mg/ml, frozen in liquid nitrogen and stored at - 80°C. Alternatively, membranes 
(P2 , B) were prepared according to Whittaker [16]. Protein was determined accord-
ing to Lowry et al. [10]. 
The binding assay was carried out in a total volume of 250 {tl of 50 mM Tris-
citrate, pH 7.1, containing 50 nM eH]phenobarbital (spec. act. 8.1 Cilmmol; NEN, 
Dreieich, F .R.G.) and approximately 300 {tg of membrane protein. Other substances 
or incubation buffers were used as indicated. Incubation was for 20 min at 20°C 
unless stated otherwise and was terminated by centrifugation at 10,000 g for 3 min 
followed by aspiration of the supernatant. [14C]sucrose (approximately 10,000 
cpm/tube) was used to correct for [3H]phenobarbital trapped with incubation buf-
fer in the pellet [12]. The tips of the tubes were cut off and counted in a dual-channel 
liquid scintillation counter. Non-specific binding was determined in the presence of 
30 mM unlabelled phenobarbital and amounted to approximately 30070 of total 
binding; data are given as specific (total minus non-specific) binding. The binding 
was found to increase linearly with protein concentrations up to 3.5 mg/ml. 
The saturation isotherm of [3H]phenobarbital binding and the linear Scatchard 
plot of the data (Fig. lA) suggest the presence of a single class of non-interacting 
binding sites. These binding sites are of low affinity (Kd = 720 {tM) and extremely 
high density (Bmax = 2.7 nmol/mg protein). Willow et al. [17] reported an almost ten 
times higher affinity; however, they also found a similarly high number of binding 
sites. For this reason it is unlikely that the binding occurred at a specific membrane 
protein; indeed, if a molecular weight of 50,000 is assumed, these binding sites 
would have to account for 15% of the membrane protein. Similarly high Bmax values 
were found using P2 and B membrane fractions with no enrichment in the B 
fraction. 
[3H]phenobarbital could be displaced from the binding sites by all barbiturates 
tested; Ki values (95% confidence limits) obtained from inhibition curves ranged 
from 0.8 (0.5-1.3) mM for thiopental to 3.1 (2.8-3.4) mM for hexobarbital. Bar-
bituric acid which is pharmacologically inactive has a Ki of 6.5 mM. Thus we could 
not reproduce the findings by Willow et al. [17] who reported marked differences 
in the affinity of the barbiturates and almost 100 times lower Ki values for 
methohexital and thiopental (8 and 11 {tM vs 0.8 and 0.9 mM). A variety of other 
compounds including diazepam, GABA, picrotoxin, ethanol, adenosine and 
N6-phenylisopropyladenosine had no effect in concentrations up to 10 mM. 
The association and dissociation of the radioligand (Fig. 1B) are complete within 
1 min and thus are too fast to be detected by equilibrium binding techniques. This 
gives further support to the notion of a binding process of low affinity. 
In order to test the hypothesis that the radio ligand binds to a non-protein site, 
binding was carried out at different temperatures ranging from O°C to 95°C (Fig. 
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Fig. 1. Characteristics of [3Hjphenobarbital binding to rat brain membranes. A: saturation isotherm. The 
membranes were incubated at 20 c C with increasing concentrations of radioligand, which was diluted 
with unlabelled phenobarbital to obtain high concentrations. The inset shows the Scatchard plot of the 
data. B, radio ligand bound (pmollmg protein); F, free radioligand (mM). A Kd=value of 721 "M and 
a Bmax value of 2.7 nmollmg protein are obtained. B: kinetics. The association of eHjphenobarbital (50 
nM) was started by addition of membrane protein and the dissociation initiated after 20 min of incuba-
tion by addition of 30 mM of unlabelled phenobarbital. Centrifugation time was reduced to 30 s so that 
total incubation times of 1 min could be obtained. C: effects of temperature. Incubation time was 20 
min at all temperatures; this was sufficient to reach equilibrium. Analysis of variance indicates no signifi-
cant influence of temperature on [3Hjphenobarbital binding. Data are the mean and S.E.M. of 3 
experiments. 
to receptors [2], did not influence the binding of [3Hjphenobarbital. Even exposi-
tion to 95°C for prolonged periods of time did not appear to alter the binding site. 
In addition, the binding site was not subject to attack by a variety of proteases, i.e. 
trypsin, chymotrypsin, pronase, elastase and papain, even in high concentrations 
(data not shown). The binding was also not affected by concentrations of 
phospholipase A2 and C or lipase which cause, for example, marked reduction of 
binding of calcium channel blockers [3j. 
Binding of radioligands to receptors usually has an optimum at physiological pH 
values [2j. In contrast to these findings, binding of [3Hjphenobarbital to brain mem-
branes was maximal at pH 5 (Fig. 2A); at lower pH the radioligand is insoluble in 
aqueous solution. This suggests that the undissociated form which predominates at 
Iow pH is preferentially bound by the membranes. This binding of the uncharged 
molecule might be due to penetration into the lipid bilayer. To test this hypothesis, 
binding of eHjphenobarbital was carried out in the presence of increasing concen-
trations of various detergents (Fig. 2B). Even in concentrations as low as 0.1070 all 
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Fig. 2. Effects of pH and detergents on eH]phenobarbital binding. A: effects of pH. The incubation 
buffers used were: 50 mM K + -phosphate buffer (e, pH 5-9) and 50 mM Tris-HCl buffer (., pH 7-10). 
B: effects of detergents. Incubation was in the presence of different concentrations of: Na + -cholate (e), 
CHAPS 1(3-cholamido-propyl)dimethylammonio]propanesulfonate: (A), Triton X-lOO (.) and lubrol 
PX (,.). All detergents were from Sigma, Miinchen, F.R.G. Data are the mean and S.E.M. of 3 
experiments. 
detergents tested decreased the binding to a considerable extent. At the same con-
centrations, binding of other radioligands to receptors, i.e. eHjphenylisopropyl-
adenosine to Al adenosine receptors or [3Hjyohimbine to CY2-adrenoceptors, in the 
same tissue was markedly increased (data not shown). To exclude the possibility that 
the binding sites had been solubilized, binding in the supernatant was tested after 
the addition of 0.15070 ,,(-globulin and 12070 polyethyleneglycol 6000. No binding 
could be detected in the supernatant obtained with any of the detergents. Therefore 
the reduction of the binding by detergents appears to be due to an interaction with 
the lipid bilayer itself. 
To summarize our results, the very high number of binding sites and their 
characteristics suggest that the binding sites for [3Hjphenobarbital and the sites 
mediating barbiturate effects on the GABA-benzodiazepine receptor complex or 
adenosine Al receptor are not identical. This hypothesis is supported by a recent 
report that barbiturate interactions with the GABA-benzodiazepine receptor com-
plex are retained in a purified receptor preparation [14j. Thus, barbiturates do not 
seem to regulate these receptors by binding to plasma membrane phospholipids as 
suggested by Willow et al. [17j. On the contrary it appears that the binding of 
[3Hjphenobarbital to brain membranes is a rather non-specific interaction with the 
plasma membrane which is also, to a lesser extent, shared by pharmacologically in-
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active barbiturates. Although this does not exclude specific interactions of bar-
biturates with membrane proteins, binding studies with [3H]phenobarbital appear 
to be of limited usefulness in order to clarify the mechanism of action of 
barbiturates. 
The authors thank Ms. I. Hermann for excellent technical assistance. This study 
was supported by the Deutsche Forschungsgemeinschaft (Schw 83/13-2). 
I Andrews, P.R. and Mark, L.M., Structural specificity of barbiturates and related drugs, 
Anesthesiology, 57 (1982) 314-320. 
2 Burt, D.R., Criteria for receptor identification. In H.l. Yamamura, S.l. Enna and M.l. Kuhar 
(Eds.), Neurotransmitter Receptor Binding, Raven Press, New York, 1978, pp. 41-55. 
3 Olossmann, H., Ferry, D.R., Liibbecke, F., Mewes, R. and Hofmann, F., Calcium channels: direct 
identification with radioligand binding studies, TIPS, 3 (1982) 431-437. 
4 Ooldstein, D.B., The effects of drugs on membrane fluidity, Ann. Rev. Pharmacol. Toxicol., 24 
(1984) 43-64. 
5 Harris, R.A., and Schroeder, F., The effects of barbiturates and ethanol on the physical properties 
of brain membranes, 1. Pharmacol. Exp. Ther., 223 (1982) 424-431. 
6 Hirsch, M.D., Barbiturate competition for TRH receptors in mouse brain: neuromodulation of 
anesthesia, Peptides, 4 (1983) 255-260. 
7 Ho, l.K. and Harris, R.A., Mechanism of action of barbiturates, Ann. Rev. Pharmacol. Toxicol., 
21 (1981) 83-111. 
8 LaBella, F.S., Is there a general anesthesia receptor, Canad. 1. Physiol. Pharmacol., 59 (1981) 
432-442. 
9 Lohse, M.l., Lenschow, V. and Schwabe, U., Interaction of barbiturates with adenosine receptors 
in rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 326 (1984) 69-74. 
10 Lowry, O.H., Rosebrough, N.l., Farr, A.L. and Randall, R.l., Protein measurement with the Folin 
phenol reagent, 1. BioI. Chem., 193 (1951) 265-275. 
11 Olsen, R.W., Drug interactions at the OABA receptor-ionophore complex, Ann. Rev. Pharmacol. 
Toxicol., 22 (1982) 245-277. 
12 Schwabe, U., Kiffe, H., Puchstein, C. and Trost, T., Specific binding of 3H-adenosine to rat brain 
membranes, Naunyn-Schmiedeberg's Arch. Pharmacol., 310 (1979) 59-67. 
13 Seeman, P., The membrane actions of anesthetics and tranquilizers, Pharmacol. Rev., 24 (1972) 
583-655. 
14 Sigel, E. and Barnard, E.A., A -y-aminobutyric acid/benzodiazepine receptor complex from bovine 
cerebral cortex, 1. BioI. Chem., 259 (1984) 7219-7223. 
15 Trudell, 1 .R., A unitary theory of anesthesia based on lateral phase separations in nerve membranes, 
Anesthesiology, 46 (1977) 5-10. 
16 Whittaker, V.P., The synaptosome. In A. Lajtha (Ed.), Handbook of Neurochemistry, Vol. 2, 
Plenum Press, New York, 1969, pp. 327-364. 
17 Willow, M., Morgan, l.O. and lohnston, O.A.R., Phenobarbitone binding sites in rat brain synap-
tosomal membranes, Neurosci. Lett., 24 (1981) 301-306. 
18 Willow, M. and lohnston, O.A.R., Enhancement of OABA binding by pentobarbitone, Neurosci. 
Lett., 18 (1980) 323-327. 
